SynthesisJournal of translational medicine2026
Effects of the Mediterranean diet on oxidative stress: a systematic review and meta-analysis of randomized clinical trials.
Synthesis in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe Mediterranean diet (MD) is rich in antioxidant components that can increase the antioxidant capacity of the body and improve the oxidative stress status. This systematic review and meta-analysis aimed to determine the ability of the MD to regulate oxidative stress status.
methodsThis study was conducted in accordance with the PRISMA guidelines. The PubMed, Embase, Cochrane Library, Web of Science, ClinicalTrials, and Chinese Clinical Trial databases were searched from their inception to November 2024. Randomized controlled trials that investigated the relationship between MD patterns and oxidative stress biomarkers were selected to assess the impact of the MD on oxidative stress markers.
resultsThe 20 studies included in the analysis encompassed 2,208 participants and examined 13 indicators. The MD increased the total blood antioxidant capacity (standardized mean difference [SMD]: 0.57, 95% confidence interval [CI]: 0.31 to 0.83; p < 0.001), decreased urine F2-isoprostanes (SMD: -0.40, 95% CI: -0.67 to -0.12; p = 0.005), and significantly decreased blood malondialdehyde levels (SMD: -0.70, 95% CI: -1.12 to -0.27; p = 0.001).
conclusionThese findings suggest that the MD can enhance the body's antioxidant capacity and improve lipid peroxidation. Therefore, an MD may be an effective method for reducing oxidative stress.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.